Severe anaphylaxis caused by intravenous anti‐cancer drugs

Author:

Horita Nobuyuki1ORCID,Miyagi Etsuko2,Mizushima Taichi1,Hagihara Maki1,Hata Chiaki1,Hattori Yuki1,Hayashi Narihiko1,Irie Kuniyasu1,Ishikawa Hideyuki1,Kawabata Yusuke1,Kitani Yosuke1,Kobayashi Noritoshi1,Kobayashi Nobuaki1,Kurita Yusuke1,Miyake Yohei1,Miyake Kentaro1,Oguri Senri1,Ota Ichiro1,Shimizu Ayako1,Takeuchi Masanobu1,Yamada Akimitsu1,Yamamoto Kojiro1,Yukawa Norio1,Masuda Munetaka3,Oridate Nobuhiko4,Ichikawa Yasushi5,Kaneko Takeshi6

Affiliation:

1. Chemotherapy CommitteeYokohama City University Hospital Yokohama Japan

2. Department of Obstetrics and Gynecology Yokohama City University Hospital Yokohama Japan

3. Department of Surgery Yokohama City University Hospital Yokohama Japan

4. Department of Otorhinolaryngology Head and Neck Surgery Yokohama City University Hospital Yokohama Japan

5. Department of Oncology Yokohama City University Hospital Yokohama Japan

6. Department of Pulmonology Yokohama City University Hospital Yokohama Japan

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3